Glucose lowering to control macrovascular disease in type 2 diabetes: treating the wrong surrogate end point? [electronic resource]
- JAMA Nov 2008
- 2051-3 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1538-3598
10.1001/jama.2008.510 doi
Cardiovascular Diseases--etiology Diabetes Mellitus, Type 2--complications Diabetic Angiopathies--etiology Humans Hypoglycemic Agents--therapeutic use Insulin Resistance